Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

Poveda Andres M.; Selle Frederic; Hilpert Felix; Reuss Alexander; Savarese Antonella; Vergote Ignace; Witteveen Petronella; Bamias Aristotelis; Scotto Nana; Mitchell Lada; Pujade-Lauraine Eric

首页> 外文期刊>Journal of Clinical Oncology >Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

【24h】

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

机译：贝伐单抗联合每周紫杉醇，聚乙二醇化的脂质体阿霉素或托泊替康治疗铂类耐药性复发性卵巢癌：随机III期AURELIA试验的化学治疗队列分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2015年第32期|共4页
作者
Poveda Andres M.; Selle Frederic; Hilpert Felix; Reuss Alexander; Savarese Antonella; Vergote Ignace; Witteveen Petronella; Bamias Aristotelis; Scotto Nana; Mitchell Lada; Pujade-Lauraine Eric;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial [J] . Poveda Andres M., Selle Frederic, Hilpert Felix, Journal of Clinical Oncology . 2015,第32期

机译：贝伐单抗联合每周紫杉醇，聚乙二醇化的脂质体阿霉素或托泊替康治疗铂类耐药性复发性卵巢癌：随机III期AURELIA试验的化学治疗队列分析
2. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial. [J] . Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Journal of Clinical Oncology . 2014,第13期

机译：贝伐单抗联合化学疗法治疗铂耐药的复发性卵巢癌：AURELIA开放标签随机III期试验。
3. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial. [J] . Eric Pujade-Lauraine, Felix Hilpert, Béatrice Weber, Journal of Clinical Oncology . 2014,第13期

机译：贝伐单抗联合化学疗法治疗铂耐药的复发性卵巢癌：AURELIA开放标签随机III期试验。
4. PIPAC-OV3: A multicenter open-label randomized two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian fallopian tube or primary peritoneal cancer [O] . Naoual Bakrin, Clemens Tempfer, Giovanni Scambia, 2018

机译：PIPAC-OV3：一项多中心开放标签随机三臂III期临床试验对加压铂-腹膜内气雾剂化疗（PIPAC）与单独化疗的铂-铂类患者对顺铂和阿霉素的无进展生存期有影响耐药的复发性上皮性卵巢癌输卵管癌或原发性腹膜癌
5. PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer [O] . Naoual Bakrin, Clemens Tempfer, Giovanni Scambia, 2018

机译：pipac-ov3：多中心，开放标签，随机，双臂期III试验对顺铂和多柔比蛋白的无进展存活的影响，作为加压腹膜内气溶胶化疗（PIPAC）与铂患者单独的化学疗法抗性复发性上皮卵巢，输卵管或原发性腹膜癌

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial

著录项

相似文献

相关主题

期刊订阅